by GlobeNewsWire | Sep 6, 2016 | Globe Newswire
Olathe, Kan., Sept. 06, 2016 (GLOBE NEWSWIRE) — ContactWendy SlateryFOR IMMEDIATE RELEASETelephone913-742-4456September 5, [email protected] Innara Health’s NTrainer System used to reduce length of stay in neonatal intensive careStudy will be...
by GlobeNewsWire | Sep 6, 2016 | Globe Newswire
PRINCETON, N.J., Sept. 06, 2016 (GLOBE NEWSWIRE) — Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that Daniel J. O’Connor, president and chief executive officer of Advaxis, will present a...
by GlobeNewsWire | Sep 6, 2016 | Globe Newswire
BASKING RIDGE, N.J., Sept. 06, 2016 (GLOBE NEWSWIRE) — Caladrius Biosciences (NASDAQ:CLBS), (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development and manufacturing services provider (PCT) with a select therapeutic...
by GlobeNewsWire | Sep 6, 2016 | Globe Newswire
100 mg and 200 mg doses of lasmiditan efficacious on headache pain freedom and most bothersome symptom free at the two-hour time point (p < 0.001)Lasmiditan was well tolerated with no significant difference in cardiovascular adverse events in patients dosed with...
by GlobeNewsWire | Sep 6, 2016 | Globe Newswire
Following Completion of AFFIRM, Tonix to Prioritize Resources for Advancing Posttraumatic Stress Disorder (PTSD) Program into Phase 3 TNX-102 SL Generally Well Tolerated; No New Safety Signals Observed NEW YORK, Sept. 06, 2016 (GLOBE NEWSWIRE) — Tonix...